The expression of Bcl-xL and Bak genes (Figures 3B, C, respectively) fluctuated 3 weeks post infection then, the levels of their expression was similar to the control levels at the end of the experiment. Interestingly, there

was a good correlation between Fas, FasL genes expression and HCV infection. www.selleckchem.com/products/sbe-b-cd.html The expression of Fas gene was check details visible until the third measurement (day 3) post infection and then disappeared by the end of the experiment. In contrast, the expression of FasL was not visible until day 21 post infection then the visibility progressively increased until the end of the experiment (Table 3 Figures 3D, E). Figure 3 Data on gene amplification. Ethidium bromide-stained 2% agarose gel (A) for Bcl2 gene amplification. Lanes 1 and 2 showed negative RT-PCR control; lane 3 showed positive amplification of CH case; lane 4 showed negative amplification of CH case; lane 5 showed positive amplification of HCC case; lane 6 showed negative amplification of HCC case; lane 7 showed positive amplification of HepG2 without https://www.selleckchem.com/products/cobimetinib-gdc-0973-rg7420.html HCV infection; lane 8 showed positive amplification of HepG2 with HCV infection. (B) For Bcl-Xl gene amplification. Lane 1 showed HepG2-positive amplification with HCV infection at day 28; lane 2 HepG2-negative

amplification without HCV infection; lane 3 and 4 showed positive amplification of CH case; lane 5 showed positive amplification of HCC case; lane 6 & 7 showed negative RT-PCR control. (C) For Bak gene amplification. lane 1 HepG2-positive amplification with HCV infection at days 59; lane 2 HepG2-negative amplification without HCV infection

lane 3 showed HepG2-negative amplification with HCV infection at days 35; lane 4 showed positive amplification of CH case; lane 5 showed positive amplification of HCC case of CH; lane 6 negative RT-PCR control. (D) for Fas gene amplification, first lane: MW, lanes 1 and 2: negative RT-PCR control, lane 3 showed HepG2-positive amplification without HCV infection, lane 4 HepG2- showed negative amplification with HCV infection at day 21, lane 5 showed negative case of HCC, lanes 6 and 7 showed positive amplification of CH and lane 8 showed positive amplification of HCC case. (E) Tau-protein kinase for FasL gene amplification, lane 1: negative RT-PCR control; lanes 2 and 3 showed HepG2-positive amplification with HCV infection at days 28 and 35 respectively; lane 4 showed HepG2-negative amplification without HCV infection; lane 5 showed negative case of CH; lanes 6 and 7 showed positive amplification of CH, lanes 8 and 9 showed positive amplification of HCC case. (F) Amplification plot of RT-PCR for housekeeping gene using Taqman probe. Caspases activity in HCV-infected HepG2 cells As shown in Figure 4, recognizable changes were observed in caspases 3, 8 and 9 throughout the course of HCV infection.